| Dr Donna Earnice Dalgetty, MD | |
|
570 Belleville Ave, Belleville, NJ 07109-1308 | |
| (973) 450-3100 | |
| (073) 450-1189 |
| Full Name | Dr Donna Earnice Dalgetty |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 570 Belleville Ave, Belleville, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891945390 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 25MA07300100 (New Jersey) | Primary |
| Entity Name | Rutgers Health Behavioral Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891956298 PECOS PAC ID: 2466346770 Enrollment ID: O20040419001021 |
News Archive
The premiere issue of an aging-focused newsletter deals with two pressing societal concerns - the economic downturn and health care reform - from the perspective of older minority adults.
As part of its continued effort to give back to the cancer communities in the cities visited during its annual scientific meeting, the Fairfax, Va.-based American Society for Therapeutic Radiology and Oncology (ASTRO) is partnering with the Kenneth B. Schwartz Center to raise awareness of cancer survivorship. The Kenneth B. Schwartz Center conducts pioneering programs to educate, train and support caregivers in the art of compassionate healthcare.
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced that is has priced an underwritten public offering of 16,000,000 shares of common stock, consisting of 8,000,000 shares to be sold by the Company and 8,000,000 shares to be sold by a selling shareholder, HealthpointCapital Partners, L.P., at a price to the public of $5.00 per share.
A newly discovered group of proteins could help treat cholesterol build-up in arteries. This build-up leads to atherosclerosis or 'hardening of the arteries', and the resulting condition, coronary heart disease, kills an estimated 124,000 each year in England and Wales.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donna Earnice Dalgetty, MD 570 Belleville Ave, Belleville, NJ 07109-1308 Ph: (973) 450-3100 | Dr Donna Earnice Dalgetty, MD 570 Belleville Ave, Belleville, NJ 07109-1308 Ph: (973) 450-3100 |
News Archive
The premiere issue of an aging-focused newsletter deals with two pressing societal concerns - the economic downturn and health care reform - from the perspective of older minority adults.
As part of its continued effort to give back to the cancer communities in the cities visited during its annual scientific meeting, the Fairfax, Va.-based American Society for Therapeutic Radiology and Oncology (ASTRO) is partnering with the Kenneth B. Schwartz Center to raise awareness of cancer survivorship. The Kenneth B. Schwartz Center conducts pioneering programs to educate, train and support caregivers in the art of compassionate healthcare.
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced that is has priced an underwritten public offering of 16,000,000 shares of common stock, consisting of 8,000,000 shares to be sold by the Company and 8,000,000 shares to be sold by a selling shareholder, HealthpointCapital Partners, L.P., at a price to the public of $5.00 per share.
A newly discovered group of proteins could help treat cholesterol build-up in arteries. This build-up leads to atherosclerosis or 'hardening of the arteries', and the resulting condition, coronary heart disease, kills an estimated 124,000 each year in England and Wales.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
› Verified 8 days ago
Ariel G Almacen, APNC Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 15 Lake St, Belleville, NJ 07109 Phone: 973-723-5664 Fax: 973-844-9659 | |
Dr. Mena Mirhom, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 973-450-2205 | |
Dr. Steven Mark Lomazow, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 50 Newark Ave, Suite 104, Belleville, NJ 07109 Phone: 973-751-5643 Fax: 973-751-1322 | |
Dr. Rahella Ahmad, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 973-450-2000 | |
Michael M Brand, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5 Franklin Avenue, Room 307, Belleville, NJ 07109 Phone: 973-751-5644 Fax: 973-751-5678 | |
Dr. Liviu Craciun, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 50 Newark Ave, Suite 104, Belleville, NJ 07109 Phone: 973-302-3122 |